- Home
- PLUR
PLUR
Pluri Inc.
as 11-20-2025 3:58pm EST
Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.
| Founded: | 2001 | Country: | Israel |
| Employees: | N/A | City: | HAIFA |
| Market Cap: | 36.9M | IPO Year: | N/A |
| Target Price: | $12.00 | AVG Volume (30 days): | 52.1K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.12 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.22 - $7.13 | Next Earning Date: | 11-12-2025 |
| Revenue: | $1,326,000 | Revenue Growth: | 121.74% |
| Revenue Growth (this year): | 97.38% | Revenue Growth (next year): | 293.97% |
Latest Pluri Inc. News
PLUR Breaking Stock News: Dive into PLUR Ticker-Specific Updates for Smart Investing
GlobeNewswire
9 days ago
Pluri and Subsidiaries Earn Multiple Industry Honors, Named as Overall BioAgriculture Company of the Year
Associated Press Finance
10 days ago
Pluri: Fiscal Q1 Earnings Snapshot
GlobeNewswire
11 days ago
Pluri Partners with Miss Universe Skincare Introducing Exosome-Enhanced Regenerative Skincare
GlobeNewswire
12 days ago
Leading Global Players Back and Fund Pluri’s Cell-Based Food and Agriculture Collaborations
Yahoo Finance Video
a month ago
AI will 'amplify, not replace' human performance: Workday CEO
Yahoo Finance
a month ago
'Premature to signal the all-clear': Markets cheered the CPI print — but Main Street isn’t feeling the relief
Benzinga
a month ago
Grant Cardone Lays Out Why His Bitcoin Real Estate Hybrid Model Will Crush REITs
CNW Group
a month ago
Media Advisory - Monday, October 27, 2025
Compare PLUR vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PLUR Pluri Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.